Bedeutung der ERBB-Rezeptorfamilie beim Urothelkarzinom der Harnblase: mRNA-Expression und prognostische Relevanz
Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance

Erstveröffentlichung
2017Authors
Erben, Philipp
Wezel, Felix
Wirtz, Ralph
Martini, Thomas
Stein, Doron
Wissenschaftlicher Artikel
Published in
Aktuelle Urologie ; 48 (2017), 4. - S. 356-362. - ISSN 0001-7868. - eISSN 1438-8820
Link to publication
https://dx.doi.org/10.1055/s-0043-110403Institutions
UKU. Klinik für Urologie und KinderurologieSubject headings
[Free subject headings]: bladder cancer | urothelial carcinoma | radical cystectomy | HER2 | ERBB2 | prognostic factors | transitional-cell carcinoma | cisplatin-based chemotherapy | phase-3 trial | long-term-survival | gemcitabine plus cisplatin | neoadjuvant chemotherapy | 2nd-line chemotherapy | perioperative chemotherapy | paclitaxel chemotherapy[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item recordThis could also interest you:
-
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
Moebus, Volker et al. (2017)Wissenschaftlicher Artikel
-
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians
Martini, Thomas et al. (2017)Wissenschaftlicher Artikel
-
Update Breast Cancer 2019 Part 4-Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
Schuetz, Florian et al. (2019)Wissenschaftlicher Artikel